Observational studyJournal of ovarian research2025
Follicular sphericity based on three-dimensional transvaginal ultrasound algorithms predicts ovarian responsiveness to in vitro fertilization.
Observational study in Journal of ovarian research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The relationship between oocyte maturation and follicle size: A comparative analysis of 2D and 3D ultrasound.Turkish journal of obstetrics and gynecology · 2026Article
- Assessment indicators of ovarian response during controlled ovarian stimulation: influencing factors and clinical value.Frontiers in endocrinology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThe principal indicators adopted for the assessment of follicular quality are still two-dimensional ultrasound(2D-US) imaging parameters, but these do not reflect the three-dimensional morphology of follicles. We herein aimed to explore novel parameters of ovarian follicles by three-dimensional ultrasound (3D-US) by comparing various follicles on the trigger day in gonadotropin-releasing hormone antagonist (GnRH-ant) stimulation cycles, and investigated the effects on ovarian responsiveness, oocyte and embryo quality.
methodsThis was a prospective observational study of women who commenced their first controlled ovarian stimulation (COS) cycle with a GnRH-ant protocol from March 2023 to March 2024. A total of 248 patients were included in the study and 3D-US scanning was conducted on the HCG administration day. Utilizied 3D-US measurement data were then implemented to calculate follicular sphericity. Population demographics, infertility work-up, and ultrasonographic biomarkers were employed to construct models for the prediction of ovarian responsiveness and embryo quality.
resultsThe ROC analysis showed that the cut-off point for enabling follicular sphericity to exert a significant effect on MII oocyte was 0.716, and the patients were assigned to two groups: low sphericity(< 0.716) and high sphericity(≥ 0.716). Applying the Wilcoxon signed-rank test and the general linear model for univariate analysis and controlling for confounders, women in the low sphericity group achieved a higher oocyte retrieval rate, MII oocyte rate, follicular output rate (FORT), ovarian sensitivity index (OSI), and Day 3-8cell rate relative to women in the high sphericity group (adjusted β = 5.46, 5.15, 1.08, 2.39, 1.17, respectively; all P value < 0.05) in patients with normal ovarian reserve.
conclusionThis study was based on 3D-US measurements, follicular sphericity reliably predicted oocyte and embryo quality during in vitro fertilization monitoring in patients with normal ovarian reserve. We observed that follicular sphericity served as an available ultrasound parameter, reflecting the follicular development in COS, and providing insights for adjusting gonadotropin drug regimens. TRIALS REGISTRATION: http://www.chictr.org.cn Identifier: ChiCTR2400085886.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.